Table 2. Attributes of patients being prescribed anti-dementia drugs (n = 863).
| Parameter | Category | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Male (n = 264) | (%) | Female (n = 573) | (%) | Overall (n = 837) | (%) | Overall (n = 863)a | (%) | ||
| Age | Mean | 23 | (8.8) | 38 | (6.7) | 61 | (7.4) | 62 | (7.3) |
| < 75 years | 40 | (15.3) | 81 | (14.4) | 121 | (14.7) | 123 | (14.5) | |
| ≥ 75 and < 80 years | 75 | (28.7) | 158 | (28.0) | 233 | (28.2) | 237 | (27.9) | |
| ≥ 80 and < 85 years | 78 | (29.9) | 169 | (30.0) | 247 | (29.9) | 253 | (29.8) | |
| ≥ 85 and < 90 years | 45 | (17.2) | 118 | (20.9) | 163 | (19.8) | 173 | (20.4) | |
| Total | 261 | (100.0) | 564 | (100.0) | 825 | (100.0) | 848 | (100.0) | |
| Nursing care level | Independent | 2 | (0.8) | 3 | (0.5) | 5 | (0.6) | 5 | (0.6) |
| Assistance required levels Ⅰ-Ⅱ | 16 | (6.2) | 30 | (5.4) | 45 | (5.6) | 46 | (5.5) | |
| Ⅰ | 53 | (20.5) | 154 | (27.6) | 205 | (25.6) | 211 | (25.2) | |
| Ⅱ | 70 | (27.1) | 150 | (26.9) | 217 | (27.1) | 224 | (26.8) | |
| Ⅲ | 49 | (19.0) | 94 | (16.9) | 139 | (17.4) | 146 | (17.4) | |
| Ⅳ | 31 | (12.0) | 56 | (10.1) | 86 | (10.7) | 94 | (11.2) | |
| Ⅴ | 30 | (11.6) | 63 | (11.3) | 90 | (11.2) | 96 | (11.5) | |
| Application pending | 1 | (0.4) | 2 | (0.4) | 3 | (0.4) | 3 | (0.4) | |
| Unknown | 6 | (2.3) | 5 | (0.9) | 11 | (1.4) | 12 | (1.4) | |
| Total | 258 | (100.0) | 557 | (100.0) | 801 | (100.0) | 837 | (100.0) | |
| Primary Disease | Circulatory disease | 29 | (11.2) | 69 | (12.1) | 96 | (11.9) | 105 | (12.3) |
| Cerebral infarction | 34 | (13.1) | 30 | (5.3) | 62 | (7.7) | 65 | (7.6) | |
| Osteoarthritis | 1 | (0.4) | 11 | (1.9) | 12 | (1.5) | 12 | (1.4) | |
| Fracture/osteoporosis | 3 | (1.2) | 8 | (1.4) | 11 | (1.4) | 13 | (1.5) | |
| Rheumatoid arthritis | 0 | (0.0) | 7 | (1.2) | 6 | (0.7) | 7 | (0.8) | |
| Amyotrophic lateral sclerosis | 1 | (0.4) | 1 | (0.2) | 2 | (0.2) | 2 | (0.2) | |
| Dementia | 153 | (58.8) | 397 | (69.9) | 539 | (66.5) | 561 | (65.9) | |
| Parkinson’s disease | 14 | (5.4) | 15 | (2.6) | 28 | (3.5) | 29 | (3.4) | |
| Other nerve disease | 4 | (1.5) | 9 | (1.6) | 13 | (1.6) | 13 | (1.5) | |
| Chronic respiratory failure | 2 | (0.8) | 3 | (0.5) | 4 | (0.5) | 5 | (0.6) | |
| Cancer | 9 | (3.5) | 8 | (1.4) | 17 | (2.1) | 17 | (2.0) | |
| Renal failure | 2 | (0.8) | 3 | (0.5) | 5 | (0.6) | 5 | (0.6) | |
| Other | 8 | (3.1) | 7 | (1.2) | 15 | (1.9) | 17 | (2.0) | |
| Total | 260 | (100.0) | 568 | (100.0) | 810 | (100.0) | 851 | (100.0) | |
| Living Situation | At home, alone | 57 | (21.6) | 164 | (28.7) | 217 | (26.6) | 225 | (26.1) |
| At home, with spouse | 81 | (30.7) | 69 | (12.1) | 148 | (18.2) | 150 | (17.4) | |
| At home, with family | 40 | (15.2) | 83 | (14.5) | 117 | (14.4) | 129 | (15.0) | |
| At home, with someone other than family | 4 | (1.5) | 3 | (0.5) | 5 | (0.6) | 7 | (0.8) | |
| Communal living with assisted care | 77 | (29.2) | 229 | (40.0) | 299 | (36.7) | 319 | (37.0) | |
| Special nursing home | 5 | (1.9) | 24 | (4.2) | 29 | (3.6) | 31 | (3.6) | |
| Total | 264 | (100.0) | 572 | (100.0) | 815 | (100.0) | 861 | (100.0) |
a: Including 26 subjects whose sex was unknown